Welcome to the Media Centre
This section provides details of new items added to the site as well as a full archive of our press releases and statements.
The opening hours for the Press Office are Monday to Friday between 9:00 and 17:00.
The Press Office
151 Buckingham Palace Road
Main telephone: 020 3080 7651
Out of hours: 07770 446 189
For urgent calls outside these press office hours please contact the duty press officer on : 07770 446 189.
We now have a Twitter channel for press releases and news statements, giving you another way to find out the latest news from the MHRA in real time.Follow @MHRApress
Press enquiries should be made through the Press Office.
Latest news and press releases
17 Dec 2014 | MHRA Christmas and New Year opening times
MHRA will be closed between 4pm on Wednesday 24 December and 10am on Monday 29 December.
17 Dec 2014 | Press Release: Faulty insulin pens recall
People with diabetes who use insulin pens manufactured by Owen Mumford are today being warned by the Medicines and Healthcare products Regulatory Agency (MHRA) to check if they have an affected lot. If they have a pen from the list of affected lots, then they should stop using them and receive a replacement at the earliest opportunity.
11 Dec 2014 | Pharmacies asked to support drug driving campaign
Department for Transport has issued a press release calling on pharmacies to support a new year campaign to help customers understand the changes to drug driving legislation coming into force in March 2015.
The Department of Health (DH) reviews its arm’s length bodies once every 3 years. This review is looking at what MHRA, the British Pharmacopeia and the Commission on Human Medicines do and how.
26 Nov 2014 | Regulator helps to create new cancer medicine facility
A brand new facility that ensures the continued supply of a critical cancer medicine forms the basis of the first case study released from the Innovation Office today at the Medicines and Healthcare products Regulatory Agency (MHRA). This new technology features a unique sterile manufacturing process that can help to treat patients with prostate and breast cancer.
Photo and image library
This section of the site includes press releases and statements issued by the MHRA.